Enabling industrial development
SEB Venture Capital's first Life Science investments were made in 1999. Since then, a total of 27 have been made, of which 20 have been divested to major industry players such as Astra Zeneca, Johnson & Johnson and Biovitrum as well as through IPOs in Stockholm and London.
Over the years has SEB Venture Capital also made a few fund investments which add up to a total of seven investments. We have also made some direct investments into other sectors than Technology and Life Science. These we have exited and they add up to 15 exits.